enGene Therapeutics Inc.
US ˙ NasdaqCM ˙ CA29286M1059

SecurityENGN / enGene Therapeutics Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership561,797 shares
Latest Disclosed Value $ 5,073,027
Point72 Asset Management, L.P. reports 53.51% decrease in ownership of ENGN / enGene Therapeutics Inc.

On February 17, 2026 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 561,797 shares of enGene Therapeutics Inc. (US:ENGN) valued at $5,073,027 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 1,208,399 shares of enGene Therapeutics Inc.. This represents a change in shares of -53.51% during the quarter. The current value of the position is $4,488,758 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F ENGENE HOLDINGS COM 29286M105 561,797 -646,602 -53.51 5,073 -38.53 0.0057
2025-11-14 2025-09-30 13F ENGENE HOLDINGS COM 29286M105 1,208,399 100 0.01 8,253 87.65 0.0138
2025-08-14 2025-06-30 13F ENGENE HOLDINGS COM 29286M105 1,208,299 -32,889 -2.65 4,398 -20.90 0.0086
2025-07-21 2025-03-31 13F/A-1 ENGENE HOLDINGS COM 29286M105 1,241,188 16,391 1.34 5,561 -31.73 0.0127
2025-05-15 2025-03-31 13F ENGENE HOLDINGS COM 29286M105 1,241,188 16,391 5,561 0.0127
2025-02-14 2024-12-31 13F ENGENE HOLDINGS COM 29286M105 1,224,797 561,797 84.74 8,145 86.15 0.0179
2024-11-14 2024-09-30 13F ENGENE HOLDINGS COM 29286M105 663,000 619,100 1,410.25 4,376 959.32 0.0111
2024-09-16 2024-06-30 13F/A-2 ENGENE HOLDINGS COM 29286M105 43,900 -138,686 -75.96 414 -86.65 0.0011
2024-08-19 2024-06-30 13F/A-1 ENGENE HOLDINGS COM 29286M105 43,900 -138,686 414 0.0011
2024-08-14 2024-06-30 13F ENGENE HOLDINGS COM 29286M105 43,900 -138,686 414 0.0011
2024-05-15 2024-03-31 13F ENGENE HOLDINGS COM 29286M105 182,586 182,586 3,095 0.0075
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.